Insulin receptor substrate-2 in β-cells decreases diabetes in nonobese diabetic mice

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4531-4540

  Norquay, Lisa D ^a   D'Aquino, Katharine E ^a   Opare Addo, Lynn M ^a   Kuznetsova, Alexandra ^a   Haas, Michael ^a   Bluestone, Jeffrey A ^b   White, Morris F ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TOLERANCE TEST; INSULITIS; MITOGENESIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE;

ANIMALS; ANTIGENS, CD3; DIABETES MELLITUS, TYPE 1; GLUCOSE; IMMUNOTHERAPY; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; MITOSIS;

EID: 70349330020     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0395     Document Type: Article

References (52)

1. Stumvoll M, Goldstein BJ, van Haeften TW 2005 Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333-1346 (Pubitemid 40501297)
2. DeFronzo RA 2004 Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835, ix
3. Reaven GM 1995 Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486
4. Anderson MS, Bluestone JA 2005 The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447-485
5. Eisenbarth GS, Jeffrey J 2008 The natural history of type 1A diabetes. Arq Bras Endocrinol Metab 52:146-155
6. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS 2005 Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220-223 (Pubitemid 40685949)
7. Zhang L, Nakayama M, Eisenbarth GS 2008 Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 20:111-118
8. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC 2007 Modestly increased β cell apoptosis but no increased β cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50:2323-2331 (Pubitemid 47512399)
9. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC 2005 Sustained β cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
10. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y 1980 Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1-13
11. Atkinson MA, Rhodes CJ 2005 Pancreatic regeneration in type 1 diabetes: dreams on a deserted islet? Diabetologia 48:2200-2202
12. Ablamunits V, Sherry NA, Kushner JA, Herold KC 2007 Autoimmunity and β cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann NY Acad Sci 1103:19-32 (Pubitemid 46791108)
13. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC 2006 Effects of autoimmunity and immune therapy on β-cell turnover in type 1 diabetes. Diabetes 55:3238-3245 (Pubitemid 44923579)
14. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS 1999 Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989-996 (Pubitemid 29226344)
15. Chatenoud L, Thervet E, Primo J, Bach JF 1994 Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123-127 (Pubitemid 24018655)
16. Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss Jr H, Ferran C, Sayegh MH 2004 Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 77:990-997 (Pubitemid 38508911)
17. Maki T, Ichikawa T, Blanco R, Porter J 1992 Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 89:3434-3438
18. Ackermann AM, Gannon M 2007 Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J Mol Endocrinol 38:193-206 (Pubitemid 46351603)
19. Alonso LC, Yokoe T, Zhang P, Scott DK, Kim SK, O'Donnell CP, Garcia-Ocaña A 2007 Glucose infusion in mice: a new model to induce β-cell replication. Diabetes 56:1792-1801 (Pubitemid 47025447)
20. Bonner-Weir S, Deery D, Leahy JL, Weir GC 1989 Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53 (Pubitemid 19021816)
21. Steil GM, Trivedi N, Jonas JC, Hasenkamp WM, Sharma A, Bonner-Weir S, Weir GC 2001 Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 280:E788-E796 (Pubitemid 32466847)
22. Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T 2007 Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 117:246-257 (Pubitemid 46048470)
23. White MF 2003 Insulin signaling in health and disease. Science 302:1710-1711
24. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF 2004 Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. J Clin Invest 114:908-916 (Pubitemid 39578718)
25. Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G, White MF 2006 Exendin-4 uses irs2 signaling to mediate pancreatic β cell growth and function. J Biol Chem 281:1159-1168
26. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M 2003 cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575-1580 (Pubitemid 36828785)
27. Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF 2003 Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes. J Clin Invest 112:1521-1532 (Pubitemid 38056278)
28. Laybutt DR, Hawkins YC, Lock J, Lebet J, Sharma A, Bonner-Weir S, Weir GC 2007 Influence of diabetes on the loss of β cell differentiation after islet transplantation in rats. Diabetologia 50:2117-2125 (Pubitemid 47373842)
29. Fox CJ, Danska JS 1998 Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47:331-338
30. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, Taniguchi E, Kumemura H, Hanada S, Maeyama M, Baba S, Koga H, Kumashiro R, Ueno T, Ogata H, Yoshimura A, Sata M 2004 Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 165:1499-1508 (Pubitemid 39435150)
31. Shi H, Tzameli I, Bjørbaek C, Flier JS 2004 Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 279:34733-34740 (Pubitemid 39318104)
32. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL 1995 Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180-191
33. Allison PD 1995 Survival analysis using SAS: a practical guide. Cary, NC: SAS Press
34. Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC 2007 Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of β-cells. Endocrinology 148:5136-5144 (Pubitemid 350012634)
35. White MF 2006 Regulating insulin signaling and β-cell function through IRS proteins. Can J Physiol Pharmacol 84:725-737 (Pubitemid 44897893)
36. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904 (Pubitemid 28157668)
37. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-1847
38. Tanabe K, Liu Z, Patel S, Doble BW, Li L, Cras-Méneur C, Martinez SC, Welling CM, White MF, Bernal-Mizrachi E, Woodgett JR, Permutt MA 2008 Genetic deficiency of glycogen synthase kinase-3β corrects diabetes in mouse models of insulin resistance. PLoS Biol 6:e37 (Pubitemid 351329051)
39. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M 2005 Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182 (Pubitemid 40321353)
40. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M 1999 Loss of cdk4 expression causes insulin-deficient diabetes and cdk4 activation results in β-islet cell hyperplasia. Nat Genet 22:44-52 (Pubitemid 29214803)
41. Kushner JA, Simpson L, Wartschow LM, Guo S, Rankin MM, Parsons R, White MF 2005 Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J Biol Chem 280:39388-39393 (Pubitemid 41713896)
42. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF 2005 Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol Cell Biol 25:3752-3762 (Pubitemid 40559580)
43. Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BG, White MF 2004 Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53:61-66
44. Atkinson MA 2005 ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54:1253-1263
45. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza RA, Butler PC 2008 β-Cell replication is the primary mechanism subserving the postnatal expansion of β-cell mass in humans. Diabetes 57:1584-1594
46. Butler PC, Meier JJ, Butler AE, Bhushan A 2007 The replication of β cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 3:758-768 (Pubitemid 47622601)
47. Mathis D, Vence L, Benoist C 2001 β-Cell death during progression to diabetes. Nature 414:792-798
48. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT 2005 A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23:115-126 (Pubitemid 41169282)
49. Louvet C, Szot GL, Lang J, Lee MR, Martinier N, Bollag G, Zhu S, Weiss A, Bluestone JA 2008 Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 105:18895-18900
50. Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA 2005 Asingle course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54:1763-1769 (Pubitemid 40770766)
51. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L 2005 Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608 (Pubitemid 41007846)
52. Chatenoud L, Primo J, Bach JF 1997 CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158:2947-2954 (Pubitemid 127470558)